RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITIVE TREATMENT
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT009022FG0210025
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $18,368
- Period of performance
- Feb 28, 2022 – Sep 30, 2022
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Place of performance
- VA
- Parent award
- HT001421A0014
Public award description
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITIVE TREATMENT
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC 6515 — Medical and Surgical Instruments, Equipment, and Supplies
- Federal market intelligence software